![Thomas Catinazzo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 3 M $ al 30/06/2026
Thomas Catinazzo is currently Chief Financial Officer at Relay Therapeutics, Inc. since 2022.
Formerly, Mr. Catinazzo was Vice President-Financial Planning & Analysis at Foundation Medicine, Inc. from 2017 to 2018.
Education includes an undergraduate degree from Boston College.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
RELAY THERAPEUTICS, INC. 0,07 % | 28/07/2026 | 158.285 ( 0,07 % ) | 3 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| RELAY THERAPEUTICS, INC. | Director Financiero/CFO | 01/04/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
| FOUNDATION MEDICINE INC | Corporate Officer/Principal | 01/04/2018 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
Relay Therapeutics, Inc.
 Relay Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage precision medicine company, which focus on enhancing small molecule therapeutic discovery in targeted oncology | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
